Abstract
The Functional Assessment of Cancer Therapy-Bone Marrow Transplant measures quality of life (QOL) in SCT patients. Prior reports found mixed results regarding QOL differences among autologous and allogeneic SCT patients. In addition, there is a paucity of literature examining differences in QOL patterns over time between autologous and allogeneic patients. The present study examines differences in QOL between patients free of clinical depression undergoing autologous (n=41) and allogeneic (n=64) SCT during early stages of treatment. Despite clinical differences, autologous and allogeneic patients demonstrated similar changes in QOL. The exception was the Functional subscale which indicated worse QOL for allogeneic patients at discharge (F test=4.61, df=1, P<0.05); allogeneic patients (Mean=13.06, s.d.=5.36) indicated they were less able to function at work and were less accepting of their illness than autologous patients (Mean=16.02, s.d.=6.73). There was a significant main effect for time on nearly all QOL subscales (P<0.05) demonstrating decline during treatment and return to baseline by discharge; only the Social Well-Being scale did not significantly change over time. These results help to understand patients’ response to SCT in the earliest stages and ultimately help identify patients at risk who could benefit from therapeutic interventions.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Andrykowski M . Psychosocial factors in bone marrow transplantation: A review and recommendations for research. Bone Marrow Transplant 1994; 13: 357–375.
McQuellon RP, Russell GB, Cella DF, Craven BL, Brady M, Bonomi A et al. Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplant 1997; 19: 357–368.
Byar K, Eilers J, Nuss S . Quality of life five or more years post-autologous hematopoietic stem cell transplant. Cancer Nurs 2005; 28: 148–157.
Heinonen H, Volin L, Uutela A, Zevon M, Barrick C, Ruutu T . Quality of life and factors related to perceived satisfaction with quality of life after allogeneic bone marrow transplantation. Ann Hematol 2001; 80: 137–143.
Stewart S . Autologous Stem Cell Transplant. A handbook for patients. Highland Park, IL: BMT InfoNet, 2006.
Pasquini M, Wang Z, Schneider L . Current use and outcome of hematopoietic stem cell transplantation: part I-CIBMTR summary slides. CIBMT Newslett 2007; 13: 5–9.
Van Besien K, Loberiza FR, Bajorunaite R, Armitage JO, Bashey A, Burns LJ et al. Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma. Blood 2003; 102: 3521–3529.
Zittoun R, Suciu S, Watson M, Solbu G, Muus P, Mandelli F et al. Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GINEMA AML 8A trial. Bone Marrow Transplant 1997; 20: 307–315.
Hjermstad MJ, Holte H, Evensen SA, Fayers PM, Kaasa S . Do patients who are treated with stem cell transplantation have a health-related quality of life comparable to the general population after 1 year. Bone Marrow Transplant 1999; 24: 911–918.
Andorsky DJ, Loberiza FR, Lee SJ . Pre-transplantation physical and mental functioning is strongly associated with self-reported recovery from stem cell transplantation. Bone Marrow Transplant 2006; 37: 889–895.
Leigh S, Wilson K, Burns R, Clark R . Psychosocial morbidity in bone marrow transplant recipients: a prospective study. Bone Marrow Transplant 1995; 16: 635–640.
Syrjala KL, Chapko MK, Vitaliano PP, Cummings C, Sullivan KM . Recovering after allogeneic marrow transplantation: prospective study of predictors of long-term physical and psychosocial functioning. Bone Marrow Transplant 1993; 11: 319–327.
Stiff P, Miller L, Mumby P, Kiley K, Batiste R, Porter N et al. Patients’ understanding of disease status and treatment plan at initial hematopoietic stem cell transplantation consultation. Bone Marrow Transplant 2006; 37: 479–489.
Trask PC, Paterson A, Riba A, Brines B, Griffith K, Parker P et al. Assessment of psychological distress in prospective bone marrow transplant patients. Bone Marrow Transplant 2002; 29: 917–925.
Gaston-Johansson F, Foxall M . Psychological correlates of quality of life across the autologous bone marrow transplant experience. Cancer Nurs 1996; 19: 170–176.
Andrykowski M, Bishop M, Hahn E, Cella D, Beaumont J, Brady M et al. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol 2005; 23: 599–608.
Worel N, Biener D, Kalhs P, Mitterbauer M, Keil F, Schulenburg A et al. Long-term outcome and quality of life of patient who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation. Bone Marrow Transplant 2002; 30: 619–626.
Grulke N, Bailer H, Kachele H, Bunjes D . Psychological distress of patients undergoing intensified conditioning with radioimmunotherapy prior to allogeneic stem cell transplantation. Bone Marrow Transplant 2005; 35: 1107–1111.
Syrjala K, Langer S, Abrams J, Storer B, Sanders J, Flowers M et al. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. JAMA 2004; 291: 2335–2343.
Mumby P, Garcia C, Trivedi-Purohit R, Gourvitz R, Rychlik K, Rodriguez T et al. The impact of pharmacotherapy on depression and quality of life in patients undergoing a bone marrow transplant. J Clin Oncol 2010; 28(15S): 668s.
Beck A, Steer R, Brown G . Beck Depression Inventory: Manual. 2d ed. Harcourt Brace: Boston, 1996.
Cella D, Tulsky D, Gray G, Sarafian B, Linn E, Bonomi A et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 1993; 11: 570–579.
Brady M, Cella D, Mo F, Bonomi A, Tulsky D, Lloyd S et al. Reliability and validity of the functional assessment of cancer therapy-breast (FACT-B) quality of life instrument. J Clin Oncol 1997; 15: 974–986.
Cella D, Bonomi A, Lloyd S, Tulsky D, Kaplan E, Bonomi P . Reliability and validity of the functional assessment of cancer therapy-lung (FACT-L) quality of life instrument. Lung Cancer 1995; 12: 199–220.
Weitzner M, Meyers C, Gelke C, Byrne K, Cella D, Levin V . The functional assessment of cancer therapy (FACT) scale: Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer 1995; 75: 1151–1161.
Faul F, Erdfelder E, Lang AG, Buchner A . G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39: 175–191.
Mosher CE, Redd WH, Rini CM, Burkhalter JE, DuHamel KN . Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature. Psychooncology 2009; 18: 113–127.
Rini C, Redd W, Austin J, Mosher C, Meschian Y, Isola L et al. Effectiveness of partner social support predicts enduring psychological distress after haematopoietic stem cell transplantation. J Consult Clin Psychol 2011; 79: 64–74.
Beeken R, Eiser C, Dalley C . Health-related quality of life in haematopoietic stem cell transplant survivors: a qualitative study on the role of psychosocial variables and response shifts. Qual Life Res 2010; 20: 153–160.
Rankin NM, Butow PN, Price MA, Evans A . Views of psycho-oncology health professionals on priority psycho-oncology research questions. Support Care Cancer 2011; 19: 1133–1141.
Jacobsen PB, Ransom S . Implementation of NCCN distress management guidelines by member institutions. J Natl Compr Canc Netw 2007; 5: 99–103.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Garcia, C., Mumby, P., Thilges, S. et al. Comparison of early quality of life outcomes in autologous and allogeneic transplant patients. Bone Marrow Transplant 47, 1577–1582 (2012). https://doi.org/10.1038/bmt.2012.77
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2012.77
Keywords
This article is cited by
-
Exercise in allogeneic bone marrow transplantation: a qualitative representation of the patient perspective
Supportive Care in Cancer (2022)
-
Functional capacity, pulmonary function, and quality of life in hematopoietic stem cell transplantation survivors
Supportive Care in Cancer (2021)
-
Allogeneic stem-cell transplantation for multiple myeloma: a systematic review and meta-analysis from 2007 to 2017
Cancer Cell International (2018)
-
Everyday life following hematopoietic stem cell transplantation: decline in physical symptoms within the first month and change-related predictors
Quality of Life Research (2018)
-
Pretransplant Psychological Assessment for Stem Cell Treatment
Journal of Health Service Psychology (2018)